<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.4" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJCI</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Clinical Innovation</journal-title>
        <abbrev-journal-title>IJCI</abbrev-journal-title>
      </journal-title-group>
      <publisher>
        <publisher-name>International Journal of Clinical Innovation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">IJCI-2026-0009</article-id>
      <title-group>
        <article-title>Intravenous Dexmedetomidine as an Adjunct to Spinal Anesthesia for Lower-Extremity Orthopedic Surgery: A Randomized Controlled Study</article-title>
        <alt-title alt-title-type="running-head">Intravenous Dexmedetomidine as an Adjunct to Spinal Anesthesia</alt-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author" corresp="yes">
          <string-name>Alfonso Gutierrez</string-name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Anesthesiology, Universidad de Carabobo</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding author:</bold> Alfonso Gutierrez. Correspondence via editorial@ijcinnovation.org.</corresp>
      </author-notes>
      <pub-date publication-format="electronic" date-type="pub">
        <day>14</day>
        <month>09</month>
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>07</month>
          <year>2026</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>09</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s).</copyright-statement>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="https://editorial.ijcinnovation.org/api/public/article-files/IJCI-2026-0009"/>
      <self-uri content-type="html" xlink:href="https://www.ijcinnovation.org/articles/IJCI-2026-0009"/>
      <abstract>
        <p>Background: Intravenous dexmedetomidine may prolong spinal anesthesia but can reduce heart rate and blood pressure. This study evaluated its effect on sensory and motor block characteristics and perioperative hemodynamics during lower-extremity orthopedic surgery.</p>
        <p>Methods: In this single-center randomized controlled study, 25 adults with American Society of Anesthesiologists physical status I-II undergoing lower-extremity surgery under spinal anesthesia were allocated by sealed-envelope selection to dexmedetomidine (Group D; n=12) or saline control (Group C; n=13). All patients received 10 mg intrathecal isobaric bupivacaine. Group D received intravenous dexmedetomidine 1 µg/kg over 10 minutes followed by 0.2 µg/kg/h; Group C received volume-matched 0.9% saline. Sensory block was assessed by pinprick, motor block by the Bromage scale, and heart rate and blood pressure at prespecified perioperative time points. Between-group comparisons used the Mann-Whitney U test.</p>
        <p>Results: Median sensory block onset was 1.0 versus 1.2 minutes (p=0.040) and motor block onset was 2.0 versus 2.5 minutes (p=0.025) in Groups D and C, respectively. Sensory block duration was 125 versus 85 minutes (p&lt;0.001), and motor block duration was 102.5 versus 65 minutes (p=0.002). Heart rate was lower in Group D after the spinal technique and at 15 minutes, 40 minutes, the end of infusion, and 40 minutes after infusion (all p&lt;0.05). Between-group blood pressure differences did not meet the prespecified p&lt;0.05 threshold. No severe hemodynamic events were reported in the source study.</p>
        <p>Conclusions: Intravenous dexmedetomidine was associated with longer sensory and motor block duration and modestly faster block onset, but also with lower perioperative heart rate. Given the small sample, absence of reported blinding, and multiple time-point comparisons, these findings should be confirmed in larger, prospectively registered trials.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd>dexmedetomidine</kwd>
        <kwd>spinal anesthesia</kwd>
        <kwd>bupivacaine</kwd>
        <kwd>lower-extremity surgery</kwd>
        <kwd>sensory block</kwd>
        <kwd>motor block</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Funding</meta-name>
          <meta-value>The author declares no funding.</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Conflicts of interest</meta-name>
          <meta-value>The author declares no conflicts of interest.</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Author contributions</meta-name>
          <meta-value>Alfonso Gutiérrez was responsible for study conception, methodology, investigation, data collection, data analysis and interpretation, and preparation and revision of the manuscript.</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Data availability</meta-name>
          <meta-value>The data supporting the findings of this study are not publicly available because they contain participant clinical information. Deidentified data may be available from the corresponding author upon reasonable request, subject to institutional and ethical requirements.</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Ethics approval</meta-name>
          <meta-value>Approved</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Consent for publication</meta-name>
          <meta-value>Not Applicable</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Trial registration</meta-name>
          <meta-value>Not registered</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation>Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893-913. doi:10.1007/s40262-017-0507-7.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation>Naaz S, Ozair E. Dexmedetomidine in current anaesthesia practice: a review. J Clin Diagn Res. 2014;8(10):GE01-GE04. doi:10.7860/JCDR/2014/9624.4946.</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation>Abdallah FW, Abrishami A, Brull R. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia: a systematic review and meta-analysis. Anesth Analg. 2013;117(1):271-278. doi:10.1213/ANE.0b013e318290c566.</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation>Kılıç ET, Aydın G. Effects of dexmedetomidine infusion during spinal anesthesia on hemodynamics and sedation. Libyan J Med. 2018;13(1):1436845. doi:10.1080/19932820.2018.1436845.</mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation>Sekar EB, Vijayaraghavan U, Sadiqbasha AM. Effect of intravenous dexmedetomidine on spinal anesthesia. Cureus. 2021;13(6):e15708. doi:10.7759/cureus.15708.</mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation>Thakkar PD, Patel DR, Shah UD, Gupta S, Dudhani R, Mirchandani B. Effect of intravenous dexmedetomidine on characteristics of spinal anaesthesia with hyperbaric bupivacaine: a prospective study. J Popul Ther Clin Pharmacol. 2024;31(2):890-895. doi:10.53555/jptcp.v31i2.4299.</mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation>Chahal S, Bhalotra AR, Singh R, Dhiman S, Singh S. Effect of intravenous dexmedetomidine on sensory block duration in spinal anesthesia for lower limb surgery: a randomized controlled trial. Braz J Anesthesiol. 2025;75(6):844672. doi:10.1016/j.bjane.2025.844672.</mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation>Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13-21. doi:10.1080/08998280.2001.11927725.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
